The Maternal, Infant, and Early Childhood Home Visiting Program (MIECHV) supports states and territories in providing voluntary, evidence-based services to new and expectant parents. MIECHV is administered by the Health Resources and Services Administration (HRSA) in collaboration with the Administration for Children and Families (ACF). Most MIECHV funds are distributed as formula grants to states and territories based on the proportion of children under age 5 in families with household incomes below the federal poverty threshold.
MIECHV is designed to promote evidence-based practice while giving states the flexibility to invest in what works for them locally. Awardees must use the majority of MIECHV funds to implement one or more home visiting models with proven results and report on benchmarks to monitor their progress. They can dedicate up to 25 percent of funds for innovation by implementing and rigorously evaluating promising approaches that do not yet qualify as evidence-based models.
Congress first authorized and funded MIECHV for 5 years in 2010. In 2015, the program received 2 more years of funding at $400 million annually through the Medicare Access and CHIP Reauthorization Act (Public Law 114-110). MIECHV expired in September 2017 but was reauthorized in February 2018 for 5 more years.